Botulinum toxin therapy of dystonia.
Dressler D, Adib Saberi F, Rosales RL.
J Neural Transm (Vienna). 2021 Apr;128(4):531-537. doi: 10.1007/s00702-020-02266-z. Epub 2020 Oct 30.
Isolated Cervical Dystonia: Diagnosis and Classification.
Albanese A, Bhatia KP, Cardoso F, Comella C, Defazio G, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Kaji R, Krauss JK, Lang A, Tan EK, Tijssen MAJ, Vidailhet M.
Mov Disord. 2023 Aug;38(8):1367-1378. doi: 10.1002/mds.29387. Epub 2023 Mar 29.
The Dystonias.
Stephen CD.
Continuum (Minneap Minn). 2022 Oct 1;28(5):1435-1475. doi: 10.1212/CON.0000000000001159.
Dystonia: Then and now.
Comella CL.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S66-S69. doi: 10.1016/j.parkreldis.2017.06.025. Epub 2017 Jun 30.
Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy-A Narrative Review of the Literature.
Odorfer TM, Volkmann J.
Toxins (Basel). 2023 Oct 9;15(10):606. doi: 10.3390/toxins15100606.
Treatment of dystonia.
Thenganatt MA, Jankovic J.
Neurotherapeutics. 2014 Jan;11(1):139-52. doi: 10.1007/s13311-013-0231-4.
Neuropathology of Dystonia.
Sharma N.
Tremor Other Hyperkinet Mov (N Y). 2019 Feb 25;9:569. doi: 10.7916/d8-j6sx-b156. eCollection 2019.
Genetics in dystonia.
Klein C.
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S137-42. doi: 10.1016/S1353-8020(13)70033-6.
Dopa-responsive dystonia.
Segawa M.
Handb Clin Neurol. 2011;100:539-57. doi: 10.1016/B978-0-444-52014-2.00039-2.
Segmental dystonia as the prominent phenotype resulting from a MICU1 splice variant in a new Indian case.
Fevga C, Ferraro F, Breedveld GJ, Savant Sankhla C, Bonifati V.
Parkinsonism Relat Disord. 2022 Oct;103:141-143. doi: 10.1016/j.parkreldis.2022.08.031. Epub 2022 Sep 9.
